Low Molecular Weight Heparin Inhibits Circulating Fibrocytes Differentiation by Modulating Neuronal Nitric Oxide Synthase and TGF-�1/Smad Pathway
Author(s) -
Xudong Xie,
Liangfeng Zhu,
Zhongying Fu,
Xiaogang Guo,
Kan Wang,
Xiaosheng Hu,
Jun-zhu Chen
Publication year - 2012
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000343334
Subject(s) - smad , transdifferentiation , western blot , flow cytometry , nitric oxide synthase , chemistry , nitric oxide , endocrinology , blot , gene isoform , medicine , transforming growth factor , microbiology and biotechnology , biology , biochemistry , stem cell , gene
Circulating fibrocytes (CFs) have been placed at the center of a number of fibrosing conditions. Recently, attention has been drawn to the non-anticoagulant activities of low molecular weight heparin (LH), especially its anti-fibrotic effects. The purpose of this study was to investigate the effects of LH on CFs differentiation and possible underlying mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom